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Editorial 
NEEDING TO KNOW? ETHICAL DILEMMAS IN 
LEPRO S Y  TREA TMENT AND CONTROL 
Summary A young man presents to  your local c1inic in  a leprosy endernic country 
with a small patch of discoloured skin on his right forearm. The diagnosis is c1ear. 
You start to explain, but the man stops you: he doesn' t  want to hear more, just 
requests the medicine. But you are 'in conflict' ,  and not just by the desire to discuss 
the situation more fully with your patient before prescribing a drog. The local public 
health team, of which you are a part, is currently evaluating the impact on the 
community' s  health of a patient education programme which necessitates informing 
ali new leprosy cases of their diagnosis. What should you do? And can bio-ethics help? 
Control of leprosy 
This story will be familiar to many health care professionals who work in leprosy endemic 
countries. Clinically, the primary aim of intervention is to treat patients in order to achieve 
their cure, and to prevent the development of associated deformities. Broader objectives of 
leprosy control, however, are to interrupt transmission of the infection, thereby reducing the 
incidence of disease so that it no longer constitutes a public health problem. 1 Prompt 
treatment of alI existing and newly detected cases with multi-drug therapy (MDT) is the 
principal method currently used. 
The most cost-effective approach for case-finding is the promotion of self-reporting of 
suspect lesions through increased community awareness about the disease and this requires 
the patient to be informed of the diagnosis. This approach should be supported by efficient 
and easily accessible treatment services for the community. 
Public heaIth and the control of infectious diseases 
For those of us working in the field of public health, our role is to work together 'to provi de 
the conditions in which people can be healthy' . 2 Rather than simply focusing our attention on 
the individual, the patient above for example, our role is to also look at the health of the wider 
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community, and decide how an individual case should be treated to provide the most benefit 
for the patient and for the community. A classical ethical dilemma in public health is whether 
to isolate an individual with an infectious disease - and therefore comprornise his or her 
freedom - for the benefit of the population. This was the situation with leprosy before 
antibiotic treatment. In some countries, this approach has recent1y led to leprosy patients 
seeking compensation from the state for their 'draconian' treatment.3 
Most situations are less clear cut than the classic textbook examples, and our man with the 
skin patch illustrates an important point. Public health interventions, like infectious disease 
control programmes, have the potential to embody an imbalance of power and capacity 
between the implementers and the recipients.4 Health professionals decide when and where to 
intervene. It is presumed that whatever harm the intervention may impose on individuaIs is 
outweighed by the good it will bring to the population as a whole. This form of practice, this 
perspective, often tends not to exemplify respect for the autonomy of the people at the 
receiving end of the intervention.5 ,6 
So, what are the questions we should ask ourselves as health care practitioners when 
deciding whether to teU a person that he or she has leprosy? What are the issues that we need 
to confront in order to ensure that we treat the individual with dignity and respect? If a person 
is found early with a skin patch and no other signs of disease, is it necessary to inform him or 
her of the diagnosis? By simply taking treatment an individual wiU be cured, and not 
revealing the diagnosis reduces the likelihood of being stigmatized by the community. 
Ethics and principies 
Proponents of bioethics teU us that ethics can provide a useful structure to help address these 
complicated problems of right and wrong actions in clinicaI medicine and public health. 
Ethics is the systematic inteUectual endeavour to guide one' s conduct by reason - that is, to 
do what there are the best reasons for doing - while giving equal weight to the interests of 
each individual who will be affected by one' s conduct.7 
Within bioethics, the approach labeUed 'principlism' has come to dorninate current 
intemational thinking in clinicaI and public health ethics. Principlism asserts that any medico­
ethical dilemma, like the one above, can be tackled by reference to the foUowing four 
principIes :  the principIe of respect for autonomy (deliberated self-rule) ; the principIe of 
beneficence (doing good) ; the principIe of non-maleficence (doing no harm); and the principIe 
ofjustice (fairness). The philosopher Raanon GiUon, an advocate of this system, has asserted 
that, along with attention to context, principlism provides a simple, accessible, and culturally 
neutral approach to thinking about ethical issues in health care .8 
Using the four principIes, a quick analysis of our case rnight look something like this .  The 
autonomy of the patient needs to be considered and respected. According to the German 
philosopher Immanuel Kant, respect for autonomy means treating others as ends in 
themse1ves and never merely as means to some (extemaUy defined) end. It is not therefore 
appropriate simply to treat and inform the patient in order to control leprosy in the 
community, or because leprosy needs to be elirninated. This is treating the patient as a 
means to a particular end. From this angle, any informed decision of the young man should be 
respected. But how has he come to his decision, and is it informed? 
The principIes of beneficence and non-maleficence identify a balance between the effort 
to he1p the person with leprosy and at the same time producing rninimal harm. The traditional 
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Hippocratic moral obligation of medicine is to provide beneficence with non-maIeficence: net 
medicaI benefit to patients with minimal harm. Here, treating the man is beneficent (and has 
social utility in reducing leprosy in the community) but telling him the diagnosis would seem 
to inflict psychological harm, at least, and be against his wishes. The principIe of justice refers 
to the fair distribution of society' s burdens and benefits, and is perhaps least relevant of the 
principIes to this case. 
In the control of leprosy, a balance is needed between moral concem for the individual 
with the disease, and concem for the community in which the disease may spread. For public 
health practitioners there is a constant tension between the rights of the individual and the 
rights of the population. But these rights need to be balanced with correlative duties. For 
example, if the community has established a system for identifying a person with leprosy, 
then the community has a duty to ensure that individuaIs are treated with dignity, fairness, 
respect and compassion. 
Context and stigma 
Leprosy is now a disease that can be treated and cured, but it is stigmatized.9 It is surrounded 
by myth, by fear, and by isolation. So, as more is discovered and understood about the 
condition, it would appear correspondingly important to engage communities in a process of 
discussion and education about leprosy, with the overarching goal of reducing the stigma 
surrounding it. In each community, however, there is a different understanding of leprosy, 
different educational information, and different perspectives on how to control the disease 
with the minimum of harm to the patient. 
With this in mind, it becomes c1ear that the approach of principlism, although helpful, is 
also somewhat simplistic . The relationship between the health care professional and the 
patient is centraI to the story and, of course, needs to be balanced, open, and to take account of 
the potential imbaIance of power between the patient and health care worker. But this 
relationship itself must be placed, and understood, within the context of who the patient is, his 
or her knowledge of the disease, the stigma in the community, as well as the health care 
systems established to support that person during treatment and rehabilitation. If there are no 
support structures, then it may not be appropriate to simply tell the person that he or she has 
leprosy. 
Ethical considerations are re1ative to the context in which they appear. While there is no 
easy solution to the case provided, there can be little doubt about the efforts needed to reduce 
the stigma of leprosy, and to create an environrnent in which inforrning the patient becomes 
an acceptable moral norm. 
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